Healios K.K., together with its subsidiaries, engages in the research, development, manufacturing, and sale of cell therapy and regenerative medicine products in Japan, Europe, and the United States. The company offers HLCM051, which is preparing for approval for the treatment of acute respiratory distress syndrome; HLCM051, which is preparing for phase 3 clinical trial for the treatment of ischemic stroke; and HLCM051, which is in phase 2 clinical trial for the treatment of trauma, as well as H...
Industry: Biotechnology
Sector: Healthcare
Phone: 81 3 4590 8006
Address:
Hibiya Mitsui Tower, 12th Floor WORK STYLING 1-1-2 Yurakucho, Chiyoda, Japan
